These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 7713100

  • 1. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J, Fleck E, Bahrmann H, Delius W, Schultheiss HP, Brunner HR.
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [Abstract] [Full Text] [Related]

  • 2. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
    Mitrovic V, Mudra H, Bonzel T, Schmidt W, Schlepper M.
    Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
    [Abstract] [Full Text] [Related]

  • 3. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL, Sorkin EM.
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
    Riegger GA.
    Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB, Rose E, Raftery ED, Lahiri A, Elder AT, Shaw TR, Henderson E, Dargie HJ.
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA.
    J Cardiovasc Pharmacol; 1990 Mar; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
    Nieminen MS, Kupari M.
    J Cardiovasc Pharmacol; 1990 Mar; 15 Suppl 2():S36-40. PubMed ID: 1691405
    [Abstract] [Full Text] [Related]

  • 13. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
    Acanfora D, Furgi G, Trojano L, Picone C, Iannuzzi GL, Rossi M, Papa A, Rengo C, Rengo F.
    Am J Ther; 1997 Mar; 4(5-6):181-8. PubMed ID: 10423609
    [Abstract] [Full Text] [Related]

  • 14. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension].
    Schmidt BM, Smilde J, Oldenbroek C, Wehling M.
    Med Klin (Munich); 1998 Dec 15; 93(12):701-6. PubMed ID: 10024837
    [Abstract] [Full Text] [Related]

  • 15. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A, Swedberg K.
    Eur Heart J; 1995 Dec 15; 16 Suppl N():65-72. PubMed ID: 8682064
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP, Elsner D, Riegger GA.
    J Cardiovasc Pharmacol; 1990 Jul 15; 16(1):9-14. PubMed ID: 1696671
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.